Research Summary

A research-grade peptide certificate reports two different analytical results because purity and identity are two different questions. High-performance liquid chromatography (HPLC) measures how pure the main component is; mass spectrometry (MS) confirms that the main component is the intended molecule. Neither answers the other's question, which is why a credible certificate reports both. This guide explains what each method shows, how to read them together, and their limits. For laboratory research use only.

Why two methods, not one

In brief: Purity and identity are independent properties. A sample can be highly pure and still be the wrong molecule, or be the right molecule contaminated with related impurities. HPLC addresses purity; MS addresses identity. Reporting only one leaves half the characterization unproven.

This is the single most useful idea for reading a certificate. When a product page shows a purity percentage but no identity method, it has answered "how clean is the main peak?" without answering "is the main peak the intended peptide?" A research-grade characterization pairs the two so both questions are closed.

What HPLC purity actually measures

In brief: HPLC separates the components of a sample as they pass through a column, and detects them as peaks. HPLC purity is the area of the target peptide's peak expressed as a percentage of the total detected peak area — commonly reported as ≥95% or ≥99%. It describes relative abundance among the species the method detects.

In practice, a sample is injected and its components elute at characteristic times, usually detected by UV absorbance at a wavelength such as 214 or 220 nm. The main peak is the target peptide; smaller peaks are typically synthesis-related impurities such as deletion or truncation sequences. The purity figure is that main peak's share of the whole. Method conditions and validation expectations for chromatographic purity are described in USP General Chapter <621>.

How to read an HPLC chromatogram

In brief: A credible certificate shows the chromatogram itself, not only the summary number. The trace lets you see how cleanly the main peak is resolved from its neighbours — a well-separated, dominant peak supports the reported figure; a crowded or poorly resolved trace does not.

When you have the chromatogram, look for a single dominant peak, clear separation from minor peaks, and a stable baseline. A reported "99%" with a messy or unshown trace is weaker evidence than a reported "98%" with a clean, resolved chromatogram. The picture qualifies the number.

What mass spectrometry confirms

In brief: Mass spectrometry measures the molecule's mass and compares it with the theoretical mass calculated from the peptide's sequence. Agreement within the instrument's tolerance indicates the synthesized molecule matches the intended structure. It confirms identity, not purity.

Electrospray ionization (ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) are the techniques most often cited on peptide certificates. Because larger peptides commonly carry several charges, a certificate may list more than one observed ion; each should reconcile with the expected mass for that charge state. The observed mass matching the theoretical mass is the identity check.

Reading the two results together

In brief: Read HPLC and MS as a pair. HPLC tells you the main component is abundant and clean; MS tells you that component is the intended peptide. Together they establish that the material is what it claims to be, at the purity it claims — the foundation for any downstream research use.

A certificate that reports strong HPLC purity and a matching mass has characterized the material properly. One that reports only purity, or only a mass, has left a gap. For how these results fit into a full certificate, see how to read and verify a peptide COA; for why a high purity figure still doesn't tell you how much peptide is in the vial, see net peptide content.

What neither method tells you

In brief: HPLC and MS characterize identity and purity of a batch at the time of testing. Neither establishes biological activity, safety, or suitability for any human or veterinary use, and neither is an FDA approval. They describe a research material; they do not authorize any application beyond qualified laboratory research.

Two further limits are worth stating. HPLC purity describes relative abundance among the species the method detects, so a purity figure is not the same as the actual peptide content by mass. And both methods describe the tested lot only — results do not transfer to other batches. Read correctly, HPLC and MS confirm a material is what it claims to be; that is where due diligence begins, not ends.

Frequently Asked Questions

HPLC measures purity — how much of the detected material is the target peptide, usually reported as ≥95% or ≥99%. Mass spectrometry confirms identity — that the molecule's measured mass matches the mass calculated from its sequence. Purity and identity are different questions, so a research-grade certificate reports both.

References

  1. U.S. Pharmacopeia — General Chapter <621> Chromatography (system suitability, peak resolution, and method parameters). (usp.org)
  2. International Council for Harmonisation — ICH Q2(R2) Validation of Analytical Procedures. (ich.org)